Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
Clinical trial NCT03493048 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03493048
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-15
- Primary completion
- 2022-12-30
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.